Estatísticas para NT 2128 2021 - BEVACIZUMABE, REGORAFENIBE - Neoplasia malígna de reto - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| NT 2128 2021 - BEVACIZUMABE, REGORAFENIBE - Neoplasia malígna de reto - NATJUS TJMG | 33 |
Total visitas por mês
| views | |
|---|---|
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 2 |
| May 2025 | 12 |
Visitas Arquivos
| views | |
|---|---|
| NT 2021.0002128 Ca de reto Bevacizumabe.pdf | 20 |